Bank of New Hampshire’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.56M | Buy |
22,570
+6,427
| +40% | +$444K | 0.39% | 74 |
|
2025
Q1 | $1.12M | Buy |
16,143
+1,699
| +12% | +$118K | 0.29% | 83 |
|
2024
Q4 | $1.24M | Sell |
14,444
-336
| -2% | -$28.9K | 0.32% | 79 |
|
2024
Q3 | $1.76M | Buy |
14,780
+648
| +5% | +$77.2K | 0.44% | 69 |
|
2024
Q2 | $2.02M | Buy |
14,132
+875
| +7% | +$125K | 0.52% | 51 |
|
2024
Q1 | $1.7M | Buy |
13,257
+12,347
| +1,357% | +$1.59M | 0.45% | 68 |
|
2023
Q4 | $94.1K | Hold |
910
| – | – | 0.03% | 258 |
|
2023
Q3 | $82.8K | Hold |
910
| – | – | 0.02% | 260 |
|
2023
Q2 | $73.6K | Hold |
910
| – | – | 0.02% | 271 |
|
2023
Q1 | $72.4K | Hold |
910
| – | – | 0.02% | 278 |
|
2022
Q4 | $62K | Hold |
910
| – | – | 0.02% | 293 |
|
2022
Q3 | $45K | Hold |
910
| – | – | 0.01% | 314 |
|
2022
Q2 | $51K | Hold |
910
| – | – | 0.01% | 309 |
|
2022
Q1 | $51K | Buy |
+910
| New | +$51K | 0.01% | 324 |
|